No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

Scientists at the Garvan Institute of Medical Research have discovered that certain gene variations associated with leukemia ...

However, despite huge success with high early response rates ... providing an important step forward in the use of CRISPR in immune cell therapies” A recent report indicates that autologous ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

CRISPR is an example of gene editing that ... that only 7 of the studies reported on the levels of tumor-specific immune response. A 2023 review noted that there are hundreds of clinical trials ...

In response to infection, immune cells stream into tissues to fight ... "We are expanding our CRISPR pooled spatial screening to profile the impacts of many types of genetic perturbations at ...